Dmitro S. Fedorenko

Dmitro S. Fedorenko

Auto-generated profile, based on publicly available information

Dmitro S. Fedorenko

Shupyk National Healthcare University of Ukraine, Kyiv

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2024 in Reproductive health of woman
Verified
Journal Article
Open access
PDF file
OGO.V. Golyanovskiy
O.V. Golyanovskiy
IKI.V. Klyuzko
I.V. Klyuzko
IGI.A. Gubar
I.A. Gubar
ASA.V. Skutnieva
A.V. Skutnieva
DFD.S. Fedorenko
D.S. Fedorenko
ІКІ.в. Клюзко
І.в. Клюзко
Worldwide there is an increased rate of caesarean section (CS), which leads to an growth in the percentage of intra- and postoperative complications compared to natural childbirth. One of such longterm complications after abdominal delivery is a scar defect on the uterus after SC (isthmocele).This literature review provides up-to-date scientific information on the etiology, risk factors, diagnosis, modern methods of correction and prevention of complications of this pathology.Isthmocele, by definition, is a scar defect after SC or a niche of the uterine wall, which has the appearance of a myometrial tear or a triangular anechoic defect of the anterior uterine wall, which can be classified as a small or large defect depending on the thickness of the residual (remaining) myometrium. Pathognomonic clinical symptoms are abnormal uterine bleeding, chronic pelvic pain, and infertility.In addition, pregnancy in the scar after SC, placenta previa or placenta accreta spectrum (PAS), rupture of the uterus in the area of the postoperative scar can be complications of this pathology during gestation.The main risk factors for isthmocele, proven to date, are previous SC and retroflexion of the uterus, and the influence of the technique of suturing the uterus during SC requires further research.In order to diagnose isthmocele and determine the thickness of the residual myometrium, transvaginal ultrasound, infusion sonohysterography with physiological solution, and magnetic resonance imaging are used.Treatment of isthmocele can be medical or surgical, depending on the size of the niche, the thickness of the remaining myometrium, the presence of symptoms and the woman’s reproductive plans. In case of refusal or contraindications to medical treatment, surgical correction of the isthmocele should be offered. Surgical treatment includes minimally invasive approaches using hysteroscopy, laparoscopy, or transvaginal techniques.Hysteroresectoscopy involves partial removal of the myometrium along the edges of the niche with coagulation of vessels. Therefore, this technique if the residual thickness of the myometrium is <3 mm should not be used in women who want to get pregnant. In these cases, myometrial repair is of primary importance and can be achieved by laparoscopic, laparotomy, or vaginal access. The review also provides information on the most serious complication of isthmocele – the development of a pregnancy in a scar/niche and modern approaches to managing such pregnancy.

28 May 2024 in Reproductive health of woman
Verified
Journal Article
Open access
PDF file
OGO.V. Golyanovskiy
O.V. Golyanovskiy
DFD.S. Fedorenko
D.S. Fedorenko
GRG.F. Roshchina
G.F. Roshchina
NHN.Ye. Heints
N.Ye. Heints
НГН.є. Гейнц
Н.є. Гейнц
Placenta accreta spectrum (PAS) is a severe obstetric pathology, in which placental tissue invades the myometrium. According to the current classification of FIGO (2019), depending on the depth of placental tissue invasion, PAS is divided into Placenta accreta – about 75% of cases, Placenta increta – 15% and Placenta percreta – up to 10% of all cases.The most severe cases associated with the delivery of pregnant women with Placenta percreta, especially with placental tissue sprouting not only the myometrium of the front wall of the uterus, but also the back wall of the urinary bladder or parametrial and paracervical tissue, which according to the FIGO classification are defined as cases of Placenta percreta with a degree of severity 3b and 3c. These are the most dangerous cases of the development of severe hemorrhagic complications, coagulopathic disorders, and the occurrence of intraoperative complications with damage to adjacent organs, primarily the bladder and intestines due to hysterectomy.This article presents for the general public of obstetricians and gynaecologists the analysis of a clinical case in a pregnant woman with complete presentation and placental ingrowth into the prostatic parametrial tissue and partial adhesion to the posterior bladder wall (Placenta previa/percreta 3c).The use of a modified interiliac incision of the anterior abdominal wall, medical and technical support with the use of modern energies (radio wave scalpel, argon plasma tissue coagulation) to minimize the volume of blood loss were described. The intervention was carried out at the main clinical base of the Department of Obstetrics and Gynaecology No. 1, the Kyiv Regional Perinatal Centre. Placenta accreta spectrum (PAS) – це тяжка акушерська патологія, за якої виникає інвазія плацентарної тканини в міометрій. За сучасною класифікацією FIGO (2019), залежно від глибини інвазії плацентарної тканини PAS поділяють на Placenta accretа – близько 75% випадків, Placenta increta – 15% i Placenta percreta – до 10% усіх випадків. Найбільш тяжкі випадки пов’язані з розродженням вагітних з Placenta percreta, особливо з пророщенням плацентарної тканини не тільки у міометрій передньої стінки матки, але й задньої стінки сечового міхура або параметральної і парацервікальної клітковини, що, за класифікацією FIGO, визначають як випадки Placenta percreta зі ступенем тяжкості 3b і 3c. Це найбільш небезпечні випадки розвитку тяжких геморагічних ускладнень, коагулопатичних порушень і виникнення інтраопераційних ускладнень з пошкодженням суміжних органів, насамперед сечового міхура і кишечника у разі проведення гістеректомії.Ця стаття представляє для широкого загалу акушерів-гінекологів аналіз клінічного випадку у вагітної з повним передлежанням і пророщенням плаценти у передміхурову параметральну клітковину і частковим прирощенням до задньої стінки сечового міхура (Placenta previa/percreta 3c).Описано використання модифікованого інтеріліакального розрізу передньої черевної стінки, медикаментозної і технічної підтримки із застосуванням сучасних енергій (радіохвильовий скальпель, аргоноплазмова коагуляція тканин) для мінімізації об’єму крововтрати. Втручання було проведено на основній клінічній базі кафедри акушерства і гінекології № 1 – у Київському обласному перинатальному центрі.

5 August 2025 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
OGOleg V. Golyanovskiy
Oleg V. Golyanovskiy
IКIvan V. Кlyuzko
Ivan V. Кlyuzko
ODOlena O. Dyadyk
Olena O. Dyadyk
DFDmitro S. Fedorenko
Dmitro S. Fedorenko
SFSerhii V. Frolov
Serhii V. Frolov
ANDREA TINELLIANDREA TINELLI
ANDREA TINELLI

20 November 2024 in UKRAINIAN JOURNAL HEALTH OF WOMAN
Verified
Journal Article
Open access
PDF file
OGO.V. Golyanovskiy
O.V. Golyanovskiy
RVR.M. Vorona
R.M. Vorona
IHI.M. Holenia
I.M. Holenia
DFD.S. Fedorenko
D.S. Fedorenko
Postpartum hemorrhage (PPH) remains one of the main causes of maternal morbidity and mortality worldwide, despite the progress of medical science and the introduction of new methods of diagnosis and therapy of hemorrhagic complications during pregnancy, childbirth and the postpartum period. Aim - to familiarize the general public with the latest recommendations of the International Federation of Gynecology and Obstetrics (FIGO, 2022) and our own experience regarding the most effective and evidence-based methods of diagnosis, therapy and prevention of PPH. Postpartum hemorrhage is classified into primary (early), which occurs when more than 500 ml of blood is lost during the first 24 hours after childbirth, and secondary (late), which occurs after 24 hours and up to 6 weeks after childbirth. The initial examination of the patient should include a rapid clinical assessment and analysis of risk factors. In order to objectify the volume of blood loss according to FIGO recommendations, the shock index (SI) should be used. Treatment should be directed at the specific cause of PPH (uterine atony, genital trauma, retained placenta and/or coagulopathy), and therapeutic steps should move from a less invasive method to a more complex and radical approach. In the case of refractory PPH, it is necessary to use the most effective modern methods of surgical hemostasis: ligation of the main uterine vessels, compression sutures on the uterus, bilateral ligation of the internal iliac arteries, methods of remodeling the lower uterine segment (LUS-1,2). The paradigm of infusion-transfusion therapy for massive PPH has changed, which is based on the concept of damage control resuscitation (DCR), which is based on warming the parturient, limited use of crystalloids, permissive hypotension tactics, early initiation of blood product transfusion, use of massive blood transfusion protocols, and targeted correction of coagulopathy. PPH prevention strategies include prenatal identification of risk factors, correction of anemia during pregnancy, active management of the third stage of labor, and intravenous administration of tranexamic acid. Conclusions. The implementation of the latest FIGO recommendations for the prevention, diagnosis, and treatment of PPH in the practice of obstetric facilities in the country will contribute to reducing maternal morbidity and mortality. The authors declare no conflict of interest.

26 February 2025 in Reproductive health of woman
Verified
Journal Article
Open access
PDF file
OGO.V. Golyanovskiy
O.V. Golyanovskiy
NHN.YE. Heints
N.YE. Heints
IKI.V. Klyuzko
I.V. Klyuzko
ODO.O. Dyadyk
O.O. Dyadyk
DFD.S. Fedorenko
D.S. Fedorenko
IHI.M. Holenia
I.M. Holenia
The most severe cases of abnormal placenta invasion (placenta accrete spectrum – PAS) are associated with the invasion of the myometrium and serosa, attachment to the bladder, cervix, parametrial tissue – placenta previa/percreta 3b and 3c according to the classification of the International Federation of Gynecologists and Obstetricians (FIGO, 2019). These are the most dangerous cases with severe hemorrhagic complications, coagulopathic disorders and the occurrence of intraoperative damage to the bladder and ureters.The objective: to determine the clinical effectiveness of various methods of delivery of pregnant women with placenta previa/percreta 3b and 3c using endovascular balloon occlusion of the abdominal aorta (EBOAA) and the internal iliac artery ligation (IIAL).Materials and methods. During 2015–2023 at the clinical bases of the Department of Obstetrics and Gynecology No. 1 of Shupyk National Healthcare University of Ukraine, a corporal/fundal cesarean section (CS) and hysterectomy were performed in 43 pregnant women with a diagnosis of placenta previa/percreta 3b and 3c at a gestational age of 35–37 weeks. The prenatal diagnosis was established according to ultrasound and magnetic resonance imaging, and the final diagnosis was confirmed by macroscopic and histopathological studies.I group (main group) included 12 women with pl. percreta 3b,c, who had CS with EBOAA before performing hysterectomy. II group (comparison one) included 14 pregnant women with the same diagnosis and who had CS and IIAL before performing hysterectomy. III group (control one) included 17 women with a similar diagnosis who had CS and hysterectomy without the use of additional surgical hemostasis methods. In all groups, monopolar diathermy, argon plasma coagulation and bipolar coagulation were used.Results. Blood loss in the main group was on average 950 ± 90 ml, in the comparison group – 1400 ± 130 ml (p1,2 < 0.05) and in the control group – 2100 ± 150 ml (p1,3 < 0.001 and p2,3 < 0.01). The average duration of the operation was 97.0 ± 9.0 min in the main group and 119.0 ± 11.0 min and 161 ± 15.0 min in the comparison and control groups, respectively (p < 0.05). Duration of the hospital stay was from 7 ± 1 day to 9 ± 1 day and up to 12 ± 2 days in groups, respectively.Conclusions. The use of innovative technology of temporary EBOAA in the delivery of pregnant women with placenta previa/percreta 3b and 3c before hysterectomy is the most clinically effective method, which significantly reduces the total volume of blood loss, the likelihood of massive bleeding and damage to adjacent organs, the duration of surgical intervention and stay in the obstetric hospital.

31 March 2025 in Reproductive health of woman
Verified
Journal Article
Open access
PDF file
OGO.V. Golyanovskiy
O.V. Golyanovskiy
OKO.YU. Kachur
O.YU. Kachur
RVR.M. Vorona
R.M. Vorona
TMT.M. Mazur
T.M. Mazur
DFD.S. Fedorenko
D.S. Fedorenko
KOK.S. Ostrovets
K.S. Ostrovets
According to the World Health Organization (WHO), as of 2022 approximately 16% of the world’s adult population aged 18 years old and over will be obese. Although overweight and obesity significantly increase the risk of adverse outcomes during pregnancy and childbirth, it is important to know that most women with a body mass index (BMI) > 25 kg/m2 will have an uncomplicated pregnancy. Therefore, it is worth highlighting the morbid obesity (MO), which is defined by the WHO as a BMI ≥ 40 kg/m2. Women with MO are at significantly increased risk of prenatal, perinatal and postpartum complications. It has been established that the rate of cesarean section (CS) in pregnant women with a BMI ≥ 50 kg/m2 approaches 50%.The objective: to present for obstetricians and gynecologists the clinical case of the optimal method of delivery of a pregnant woman with MO and severe preeclampsia using supraumbilical laparotomy and fundal CS, medical and technical support (radio wave scalpel, argon plasma tissue coagulation) for the prevention of peripartum complications. The operation was performed at the main clinical base of the department – in Kyiv Regional Perinatal Center.The use of suprapubic laparotomy incisions during CS in pregnant women with MO leads to significant complications due to difficult retraction of subcutaneous adipose tissue (panniculus), which significantly reduces the visibility of the surgical space, causes difficulties during fetal extraction and increases the likelihood of complications in the mother and fetus.Having analyzed the successfully implemented clinical case, it is worth noting all the obvious advantages of supraumbilical laparotomy and fundal CS in pregnant women with MO, namely: optimal access to the fundus and body of the uterus, easy fetal extraction, reduction of blood loss, postoperative pain and the likelihood of purulent-inflammatory postpartum complications, faster recovery after surgery and reduction of the duration of the woman’s stay in the hospital. The results of the clinical case are consistent with the available data in the scientific literature on this issue.